hyrimoz - adalimumab - adaz injection, solution
(Adalimumab-Adaz)Sandoz Inc
Usage: Hyrimoz is a TNF-blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis (age 2+), psoriatic arthritis, ankylosing spondylitis, Crohn's disease (adults/pediatric age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa (age 12+), and non-infectious uveitis (adults/pediatric age 2+).